Louise Rodino-Klapac
Chief Scientific Officer, Sarepta Therapeutics.
Companies
- Sarepta TherapeuticsPresident Aug 6, 2025 to now1
- Sarepta TherapeuticsChief Scientific Officer Dec 14, 2020 to now2
Holdings
Stock this person has reported owning, from the forms officers and directors file with the SEC. See the biggest insider stakes.
Shares held
Sarepta Therapeutics SRPT203,900 shares3$3.6M at $17.71Sep 4, 2026
As of each latest filing. The line shows shares held over time.
Recent filings
- Sep 4, 2026Shares withheld for tax 21,423 shares at $22.22 of Sarepta Therapeutics3
- Mar 11, 2026Shares withheld for tax 948 shares at $17.03 of Sarepta Therapeutics4
- Mar 9, 2026Shares withheld for tax 895 shares at $16.95 of Sarepta Therapeutics5
- Mar 9, 2026Shares withheld for tax 504 shares at $16.95 of Sarepta Therapeutics5
- Mar 2, 2026Shares withheld for tax 767 shares at $16.20 of Sarepta Therapeutics6
- Mar 2, 2026Shares withheld for tax 3,718 shares at $16.20 of Sarepta Therapeutics6
- Mar 1, 2026Exercised options 8,125 shares of Sarepta Therapeutics6
- Nov 17, 2025Shares withheld for tax 4,582 shares at $18.42 of Sarepta Therapeutics7
- Sep 3, 2025Granted 50,000 shares of Sarepta Therapeutics8
- Sep 3, 2025Granted 93,875 shares of Sarepta Therapeutics8
- Mar 10, 2025Granted 8,276 shares of Sarepta Therapeutics9
- Mar 10, 2025Shares withheld for tax 2,539 shares at $100.13 of Sarepta Therapeutics9
- Mar 10, 2025Shares withheld for tax 924 shares at $100.13 of Sarepta Therapeutics9
- Mar 7, 2025Shares withheld for tax 7,990 shares at $103.70 of Sarepta Therapeutics10
- Mar 7, 2025Shares withheld for tax 514 shares at $103.70 of Sarepta Therapeutics10
- Mar 7, 2025Exercised options 5,500 shares of Sarepta Therapeutics9
- Mar 6, 2025Exercised options 17,500 shares of Sarepta Therapeutics10
- Mar 4, 2025Shares withheld for tax 1,704 shares at $101.34 of Sarepta Therapeutics11
- Mar 3, 2025Shares withheld for tax 715 shares at $103.77 of Sarepta Therapeutics12
- Nov 18, 2024Shares withheld for tax 4,558 shares at $102.89 of Sarepta Therapeutics13
- Jun 24, 2024Shares withheld for tax 2,182 shares at $164.64 of Sarepta Therapeutics14
- Jun 21, 2024Exercised options 6,250 shares of Sarepta Therapeutics14
- Mar 8, 2024Shares withheld for tax 909 shares at $123.14 of Sarepta Therapeutics15
- Mar 7, 2024Shares withheld for tax 512 shares at $120.49 of Sarepta Therapeutics15
- Mar 4, 2024Shares withheld for tax 1,728 shares at $125.32 of Sarepta Therapeutics16
Sources
The numbers on this page point here. Each one links to the record it came from.
- 1SEC EDGARSarepta Therapeutics, President
- 2
- 3
- 4SEC EDGARForm 4 filed Mar 13, 2026
- 5SEC EDGARForm 4 filed Mar 11, 2026
- 6SEC EDGARForm 4 filed Mar 3, 2026
- 7SEC EDGARForm 4 filed Nov 19, 2025
- 8SEC EDGARForm 4 filed Sep 5, 2025
- 9SEC EDGARForm 4 filed Mar 11, 2025
- 10SEC EDGARForm 4 filed Mar 10, 2025
- 11SEC EDGARForm 4 filed Mar 6, 2025
- 12SEC EDGARForm 4 filed Mar 4, 2025
- 13SEC EDGARForm 4 filed Nov 20, 2024
- 14SEC EDGARForm 4 filed Jun 25, 2024
- 15SEC EDGARForm 4 filed Mar 11, 2024
- 16SEC EDGARForm 4 filed Mar 6, 2024